Susceptibility Testing of Extensively Drug-Resistant and Pre-Extensively Drug-Resistant Mycobacterium tuberculosis against Levofloxacin, Linezolid, and Amoxicillin-Clavulanate

Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis

(2011) T. Schön et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Treatment Outcomes and Survival Based on Drug Resistance Patterns in Multidrug-resistant Tuberculosis

(2010) Doh Hyung Kim et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Fluoroquinolone Resistance amongMycobacterium tuberculosisStrains from Karachi, Pakistan: Data from Community-Based Field Clinics

(2010) Yasraba Rafiq et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment Outcomes among Patients with Extensively Drug‐Resistant Tuberculosis: Systematic Review and Meta‐Analysis

(2010) Karen R. Jacobson et al.   CLINICAL INFECTIOUS DISEASES

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data

(2010) K. A. Angeby et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis

(2009) W.-J. Koh et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibiotic resistance among Salmonella enterica serovars Typhi and Paratyphi A in Pakistan (2001-2006)

(2009) Rumina Hasan et al.   Journal of Infection in Developing Countries

In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis Complex Isolated in Taiwan over 10 Years

(2008) T.-S. Huang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Case Series Report of a Linezolid-Containing Regimen for Extensively Drug-Resistant Tuberculosis*

(2008) Rany Condos et al.   CHEST

Comprehensive Treatment of Extensively Drug-Resistant Tuberculosis

(2008) Carole D. Mitnick et al.   NEW ENGLAND JOURNAL OF MEDICINE